Absolute Return Capital’s ResMed RMD Stock Holding History

Absolute Return Capital’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-1,347	Closed	-$76K	–	588
2015 Q2	$76K	Buy	+1,347	New	+$85K	﹤0.01%	542
2014 Q2	–	Sell	-4,049	Closed	-$181K	–	1351
2014 Q1	$181K	Sell	4,049 -168,482	-98%	-$7.57M	﹤0.01%	1051
2013 Q4	$8.12M	Buy	172,531 +4,098	+2%	+$207K	0.09%	264
2013 Q3	$8.9M	Sell	168,433 -13,901	-8%	-$674K	0.12%	231
2013 Q2	$8.23M	Buy	+182,334	New	+$8.65M	0.11%	232

Other funds holding RMD

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Absolute Return Capital's RMD Position: Q3 2015 in Review

Absolute Return Capital sold out of ResMed (RMD) in Q3 2015, closing a stake of 1,347 shares — an estimated $76K sold.

Absolute Return Capital first reported a position in RMD in Q2 2013 and held it in 5 quarters. The position peaked at $8.9M in Q3 2013. 313 funds tracked by Wall St. Rank hold RMD as of Q3 2015.

Absolute Return Capital reported no remaining ResMed position as of Q3 2015 after selling out during the quarter.
Absolute Return Capital sold 1,347 ResMed shares in Q3 2015, an estimated $76K.
Absolute Return Capital first reported a position in ResMed in Q2 2013 and held it in 5 quarters.
Absolute Return Capital's ResMed position peaked at $8.9M in Q3 2013.
313 funds tracked by Wall St. Rank held ResMed as of Q3 2015.

Based on Absolute Return Capital's 13F filing for Q3 2015, filed 13 Nov 2015.